Other Cancer Clinical Trials
In active follow-up
ICCG FEMTX Trial: Adjuvant phase III randomised study of high dose methotrexate and 5-Fluorouracil combined with epirubicin (FEMTX) versus control in patients with resected gastric cancer.
Closed to recruitment
MARS: Mesothelioma and radical surgery trial.
In the Clinical Trials Section
